ZRANB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.269600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.051400E-01
Normal-vs-Stage2
4.316400E-01
Normal-vs-Stage3
1.764850E-01
Normal-vs-Stage4
5.098200E-01
Stage1-vs-Stage2
5.320400E-01
Stage1-vs-Stage3
1.405250E-01
Stage1-vs-Stage4
6.121200E-01
Stage2-vs-Stage3
1.378230E-01
Stage2-vs-Stage4
2.505200E-01
Stage3-vs-Stage4
9.619500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.336600E-01
Normal-vs-AfricanAmerican
1.660770E-01
Normal-vs-Asian
4.048800E-01
Caucasian-vs-AfricanAmerican
4.171200E-01
Caucasian-vs-Asian
6.132000E-01
AfricanAmerican-vs-Asian
7.462600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.188000E-01
Normal-vs-Female
4.416200E-01
Male-vs-Female
5.181600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.831800E-01
Normal-vs-Age(41-60Yrs)
4.812800E-01
Normal-vs-Age(61-80Yrs)
4.080200E-01
Normal-vs-Age(81-100Yrs)
3.852800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.950200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.179000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.822200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.637800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.179030E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.832600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.083200E-01
Normal-vs-Daily Drinker
4.120400E-01
Normal-vs-Weekly Drinker
3.708200E-01
Normal-vs-Occasional Drinker
5.006200E-01
Normal-vs-Social Drinker
4.942200E-01
Non Drinker-vs-Daily Drinker
9.673400E-01
Non Drinker-vs-Weekly Drinker
5.401800E-01
Non Drinker-vs-Occasional Drinker
2.358000E-01
Non Drinker-vs-Social Drinker
2.539000E-01
Daily Drinker-vs-Weekly Drinker
5.523200E-01
Daily Drinker-vs-Occasional Drinker
3.009000E-01
Daily Drinker-vs-Social Drinker
3.160000E-01
Weekly Drinker-vs-Occasional Drinker
1.222580E-01
Weekly Drinker-vs-Social Drinker
1.004580E-01
Occasional Drinker-vs-Social Drinker
9.543800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.385800E-01
Normal-vs-Grade 2
5.396400E-01
Normal-vs-Grade 3
1.347420E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.955190E-01
Grade 1-vs-Grade 3
1.309590E-01
Grade 1-vs-Grade 4
3.385800E-01
Grade 2-vs-Grade 3
5.657200E-01
Grade 2-vs-Grade 4
5.396400E-01
Grade 3-vs-Grade 4
1.347420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.800200E-01
Normal-vs-NonDiabetic
4.261200E-01
Diabetic-vs-NonDiabetic
2.244600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.199800E-01
Normal-vs-NoPancreatitis
4.142800E-01
Pancreatitis-vs-NoPancreatitis
9.902000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.287200E-01
Normal-vs-N1
4.247600E-01
N0-vs-N1
9.421400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.004800E-01
Normal-vs-TP53-NonMutant
4.614400E-01
TP53-Mutant-vs-TP53-NonMutant
4.818600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
